Literature DB >> 28976562

Seroprevalence of lymphocytic choriomeningitis virus and Ljungan virus in Finnish patients with suspected neurological infections.

Cristina Fevola1,2, Suvi Kuivanen3, Teemu Smura3, Antti Vaheri1, Hannimari Kallio-Kokko3, Heidi C Hauffe2, Olli Vapalahti3,4, Annemarjut J Jääskeläinen3.   

Abstract

Directly-transmitted rodent-borne zoonotic viruses, such as lymphocytic choriomeningitis virus (LCMV) can cause nervous system infections. Rodent-borne Ljungan virus (LV) is considered potentially zoonotic possibly causing neurological symptoms. Our objective was to understand the role of these two viruses compared to other pathogens in causing neurological infections in Finnish patients. Routine screening data were available for 400 patients aged 5-50 years, collected from December 2013 to December 2014 with suspected neurological infection. Depending on symptoms, patients were variously tested for herpesviruses, enteroviruses, varicella zoster virus, and Mycoplasma pneumoniae, while those suspected of tick bite were further tested for Borrelia spp. and tick-borne encephalitis virus using antibody and/or nucleic acid tests. For 380 patients, we also screened the RNA and antibody prevalence of LCMV and LV in order to test if either of these viruses were the causative agent. Data collected indicated that the causative microbial agent was confirmed in only 15.5% of all Finnish patients with neurological symptoms, with M. pneumoniae (26 cases) being the most common causative agent found in sera, whereas Borrelia spp. (15), herpes simplex viruses (7), and enteroviruses (5) were the most common agents confirmed in the CSF. The seroprevalences for LV and LCMV were 33.8% and 5.0%, respectively, but no samples were PCR-positive. In this study, M. pneumoniae and Borrelia spp. were the most common causative agents of neurological infections in Finland. No LCMV or LV infections were detected. We conclude there was no association of LV with neurological diseases in this patient cohort.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mycoplasma pneumoniae; arenavirus; enterovirus; herpes simplex virus; neuroborreliosis; parechovirus

Mesh:

Year:  2017        PMID: 28976562     DOI: 10.1002/jmv.24966

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Viral Strain Determines Disease Symptoms, Pathology, and Immune Response in Neonatal Rats with Lymphocytic Choriomeningitis Virus Infection.

Authors:  Jeffrey M Plume; Dylan Todd; Daniel J Bonthius
Journal:  Viruses       Date:  2019-06-14       Impact factor: 5.048

2.  Prevalence and Risk Factors for Lymphocytic Choriomeningitis Virus Infection in Continental Croatian Regions.

Authors:  Tatjana Vilibic-Cavlek; Tena Oreski; Misa Korva; Branko Kolaric; Vladimir Stevanovic; Snjezana Zidovec-Lepej; Irena Tabain; Pavle Jelicic; Bozana Miklausic-Pavic; Vladimir Savic; Ljubo Barbic; Tatjana Avsic-Zupanc
Journal:  Trop Med Infect Dis       Date:  2021-04-29

Review 3.  Lymphocytic Choriomeningitis-Emerging Trends of a Neglected Virus: A Narrative Review.

Authors:  Tatjana Vilibic-Cavlek; Vladimir Savic; Thomas Ferenc; Anna Mrzljak; Ljubo Barbic; Maja Bogdanic; Vladimir Stevanovic; Irena Tabain; Ivana Ferencak; Snjezana Zidovec-Lepej
Journal:  Trop Med Infect Dis       Date:  2021-05-25

4.  Lymphocytic Choriomeningitis Virus Infections and Seroprevalence, Southern Iraq.

Authors:  Hussein Alburkat; Anne J Jääskeläinen; Ali M Barakat; Hassan J Hasony; Tarja Sironen; Haider Al-Hello; Teemu Smura; Olli Vapalahti
Journal:  Emerg Infect Dis       Date:  2020-12       Impact factor: 6.883

5.  Evolutionary Relationships of Ljungan Virus Variants Circulating in Multi-Host Systems across Europe.

Authors:  Chiara Rossi; Nicola Zadra; Cristina Fevola; Frauke Ecke; Birger Hörnfeldt; René Kallies; Maria Kazimirova; Magnus Magnusson; Gert E Olsson; Rainer G Ulrich; Anne J Jääskeläinen; Heikki Henttonen; Heidi C Hauffe
Journal:  Viruses       Date:  2021-07-07       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.